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anterior rectal wall was 4.45 Gy (range 0.06-11.3). Median A-P and 
transverse diameter measured on pre-operative CT were 40 mm 
(range 27-60) and 50 mm (range 35-67) respectively. Median A-P 
diameters on intra-operative ultrasound were 30 mm (range 22-43) 
and 32 mm (range 24-47) with and without prostate compression, 
respectively. The most used collimator (41.6%) had a 5.5 cm diameter 
(range 4.5–7). A bevel angle of 30° was used in 96.4% of cases; 9 and 
12 MeV beam energy were used in 50% of cases, respectively. All cases 
were discussed in a multidisciplinary meeting. IORT procedure lasted 
30' in average (range 15-45). 
Conclusions: The definition of a program of QA was useful in such a 
multidisciplinary and complex procedure as IORT. The increasing 
expertise of the staff over time allowed to optimize the procedure 
that resulted feasible and safe.  
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Purpose/Objective: To compare Radiochromic films and MOSFET 
measurements with Monte Carlo simulation in RW3 slab phantom with 
air gap in order to analyze overdosage measured with MOSFET during 
intraoperative electron radiotherapy in breast cancer treatment. 
Materials and Methods: Patients affected by early-stage breast 
cancer underwent IOERT, treatments were performed using a mobile 
Linear accelerator (4, 6, 8, 10 MeV electron beams; LIAC, Sordina 
S.p.A., Italy). Dose was prescribed at the deeper part of the target 
normalized at 90%. MOSFET (BestMedical, Canada) detectors, placed 
inside a sterile catheter, fixed at the centre of the PTFE side of a 
shielding disk used to minimize the thoracic wall irradiation, were 
used in clinical routine to determine the dose collected by the deeper 
part of the target. Readings at half treatment in the 18% of cases are 
higher than 10%. Our hypothesis is that air gaps and non homogeneous 
tissues can create high dose hot spot in the irradiated glandular 
tissue. We have first simulate air gap and non homogeneous tissue 
using a filled water glove and a dose calibrated GAFCHROMIC® MD-V2-
55 radiochromic film interposed between the glove and the PTFE 
plate, the air gap is between two 'fingers',then as a second step, to 
have a reproducible set-up, we have used a RW3 slab phantom with 
variable air gaps: high range: 0.5 - 1 cm and large range: 0.2-0.5 cm 
with the film interposed in the same way. Monte Carlo simulation 
(EGSnrc/BEAMnrccode, 1 mm simulation step, voxel dimension 
1x5mmx29mm) has been utilized with an gap 1 cm high and 0.2 and 
0.5 cm large. 
Results: MD-V2-55 film interposed between glove and PTFE disk shows 
overdosages until 15% in the interface between water and air, the 
same values were found with RW3 slab phantom and with Monte Carlo 
simulation. Figure1A shows MD-V2-55 profiles obtained in phantom at 
different air gap dimension and Figure1B shows Monte Carlo 
simulation profile with the same phantom, the peak is 14% high. 
 
  
Conclusions: Monte Carlo simulation and MD-V2-55GAFCHROMIC® film 
measurements might confirm that overdosage measured during IOERT 
breast cancer treatment might be due to nonhomogeneous tissues and 
air gaps, the next step will be to used MD-V2-55 GAFCHROMIC® film in 
vivo during IOERT to investigate dose distribution along the irradiated 
volume. 
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Purpose/Objective: To check accuracy and uniformity of the dose 
delivered to the breast lumpectomy target during intraoperative 
electron beam radiotherapy (IOERT): we analyzed and compared 
radiochromic film and MOSFET reading in a sample of 19 patients. 
Materials and Methods: 459 patients affected by early-stage breast 
cancer underwent IOERT, treatments were performed using a mobile 
Linear accelerator (4, 6, 8, 10 MeV electron beams; LIAC, Sordina 
S.p.A., Italy),using cylindrical applicators and steel-PTFE plates 
(3mm+3mm) placed between the residual breast and the pectoralis 
muscle to minimize the thoracic wall irradiation. Dose was prescribed 
at the deeper part of the target normalized at 90%. MOSFET (Best 
Medical, Canada) detectors, placed inside a sterile catheter, fixed at 
the centre of the PTFE side of the shielding disk, were used in clinical 
routine to determine the dose collected by the deeper part of the 
target. Delivered dose is divided in two parts and monitor unit are 
corrected if MOSFET reading exceed 10% of prescribed dose. Readings 
at half treatment in the 18% of cases are higher than 10%, therefore in 
a sample of 19 patient, in order to analyse dose uniformity along the 
target, a GAFCHROMIC® MD-V2-55 radiochromic film was interposed 
between MOSFET and shielding disk. The two detectors were 
calibrated at theLinac electron beam energies in the same geometry 
of daily dosimetry check. MD-V2_55 2D profile are acquired in region 
clearly patchy to determine: hot spot 2D dimension (width at half 
height) and hot spot value (HSV) defined as the % difference between 
expected dose and the mean between the maximum dose found in the 
hot spot and the respective 95%; HSV has been defined considering 
that dose prescription is assigned at R90, therefore a plus 10% in dose 
values is get in.  
Results: 6/19 (31%) of GAFCHROMIC® MD-55 exposed films have shown 
occasional hot spot regions with values higher than 15%, Figure1 
shows an example of exposed film and Table1 analysed HSV, hot spot 
size and taken up percentage of film size .HSV mean values: 26+2 Gy, 
mean size 1.4 +0.3cm2 and mean percentage between hot spot size 
and the corresponding irradiated film is 7.6%. 
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Conclusions: GAFCHROMIC® MD-V2-55 radiochromic films has been an 
useful tool to know real dose administration along the breast target 
and to understand some abnormal MOSFET reading. 
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Purpose/Objective: To report outcomes for patients treated with 
salvage surgical resection and intraoperative radiotherapy (IORT) for 
residual or recurrent squamous cell carcinoma (SCC) of the anus after 
primary chemoradiotherapy (CRT). 
Materials and Methods: The prospective radiation oncology 
department IORT database was searched for patients treated with 
surgery and IORT for anal SCC. Thirty-two patients treated between 
1993 and 2012 were identified. All patients had previously received 
primary concurrent CRT and had residual or recurrent disease based 
on clinical findings and/or tissue confirmation. All patients with 
recurrent disease received pre-operative, limited field external beam 
re-irradiation (median dose 30 Gray) and concurrent chemotherapy. 
IORT was utilized due to concern that salvage surgery alone would be 
unlikely to remove all gross and/or microscopic disease. Treatment-
related adverse events were classified according to the National 
Cancer Institute – Common Toxicity Criteria Adverse Events (AEs). 
Overall survival (OS), disease-free survival (DFS), central failure (CF; 
within the IORT field), local-regional failure (LRF; tumor bed or 
draining lymphatics), and distant failure (DF) were estimated using 
the Kaplan-Meier technique. 
Results: Median age at IORT was 53 years (range 34-87). Twenty-six 
patients (81%) were female. Salvage treatment was performed for 
residual disease after CRT (n=9), 1st recurrence after CRT (n=17), or 
2nd recurrence after CRT and salvage abdominal-perineal resection 
(APR, n=6). APR was a component of the multimodality salvage 
attempt in 22 patients. Extent of surgical resection was R0 (negative 
margins, n=16), R1 (microscopic residual, n=13), or R2 (macroscopic 
residual, n=3). IORT was delivered with electron beams (n=31) or high-
dose rate brachytherapy (n=1). Median IORT dose was 12.5 Gray 
(range 7.5 – 20). Median length of hospital stay was 9 days.  
Nine patients (28%) were alive at last follow-up. The median follow-up 
duration was 1.6 years for all patients and 6.3 years for living 
patients. Mortality at 30 days after surgery and IORT was 0%. Fifteen 
patients (47%) experienced a total of 16 grade 3 treatment-related 
AEs. The most common Grade 3 AEs were wound complications (n=6), 
bowel obstruction (n=5), and ureteral obstruction (n=3). There were 
no grade 4 or 5 AEs. The 5-year estimates of OS and DFS were 23% and 
17%, respectively. The 5-year estimates of CF, LRF, and DF were 26%, 
64%, and 48%, respectively. 
Conclusions: In this heavily pre-treated, high-risk patient population, 
aggressive salvage surgery and IORT was associated with long-term 
survival in a small, but significant subset of patients. 
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Purpose/Objective: Breast conserving therapy (BCT) with 
complementary radiotherapy is an effective alternative for 
mastectomy what was confirmed by comparable survivals in 20-years 
observations of randomized trials. Standard procedure after BCT is 
whole breast irradiation with higher dose on tumor bed. The dose 
escalation may be proceeded by brachytherapy, intraoperative 
radiotherapy (IORT) and conformal radiotherapy (3D-CRT) from 
external beams.  
The purpose of this paper was to report four years of IORT during 
breast-conserving surgery (BCS) as a tumor bed boost using high 
energy electrons. 
Materials and Methods: Between May 2008 and November 2012 in 255 
breast cancers treated IORT as a tumor bed boost was applied using 
electron accelerator Mobetron 1000 (IntraOp Medical, Inc.). IORT 
boost (10 Gy) was followed by whole-breast external beam 
radiotherapy (EBRT) – 25 fractions 2.0 Gy each or 15 fractions of 2.7 
Gy each for patients registered in multi-center HIOB trial 
(Hypofractionated Whole-Breast Irradiation preceded by Intra-
Operative Radiotherapy with Electrons as anticipated Boost).  
150 patients were analyzed to evaluate the risk of local failure after 
BCT, IORT boost and EBRT with minimal observation period of 1 year. 
The clinical profile is presented in table. 
After tumor excision, shielding plate was placed on a patient's chest 
wall, underneath breast tissues. Appropriate applicator size and tip 
bevel were chosen to cover whole tumor bed with specified IORT 
margins. Electron energy was precisely chosen to assure homogeneous 
dose distribution and to deliver 10 Gy to the 90% isodose, which 
reaches shielding plate surface, independently of tissue thickness. 
Acrylic bolus caps, if needed, were placed on the surface of tumor 
bed. 
 
  
Results: There was no local failure in analyzed group of patients. 
Median age of treated women was 58 years (35 to 77). Patients were 
treated using all available electron beam energies: 6 MeV was used in 
52% cases but also 9 MeV, 4 MeV and 12 MeV (33%, 13% and 2% cases 
respectively) were used for treatment. In 51% cases applicator size 
(which is related to the tumor bedsize) was 5 cm in diameter. The 
smallest used applicator was 4 cm in diameter(27% cases) and the 
largest one was 7 cm (1%). This results in average planning target 
volume - PTV (volume of tissue encompassed by the 90% isodose line) 
of35.31 cc ranging from 12.00 cc to 75.35 cc. In 56% cases no bolus 
was needed; 0.5 cm bolus was used in 83 cases (33%). In all treatment 
procedures aluminium-lead shielding plates were used, 82% of which 
were 0.5 cm thick. The thickness of irradiated breast gland was less 
than 1.5 cm in half of treated cases and between 1.5 cm and 2 cm in 
40%. Breast gland thicker than 2.5 cm was irradiated only in 3% of all 
treated cases (figure). 
 
Conclusions: Intraoperative radiotherapy as a tumor bed boost during 
breast-conserving surgery for breast cancer using high-energy 
electrons from a mobile linear accelerator is proved to be effective 
and perspective treatment procedure. 
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